-
Noosha Aubel: roční základní plat 143 056 eur — a obyvatelé Postupimi mají sloužit jako dojné krávy
-
Renshaw ends long wait to put Australia on top in first S.Africa Test
-
Romero claims Atletico late win at Alaves
-
ヌーシャ・アウベル:年間基本給143,056ユーロ――ポツダム市民は金づるとして負担を強いられる
-
Zelensky blasts diesel deal as Russian strikes kill 16
-
Noosha Aubel: 143 056 euro rocznego wynagrodzenia zasadniczego - a mieszkańcy Poczdamu mają służyć za dojne krowy
-
Arsenal back on track after Leeds scare, five-star Chelsea run riot
-
努莎・奧貝爾:年基本薪資143,056歐元——波茨坦市民卻得充當搖錢樹埋單
-
Bayern draw at Augsburg despite conceding fastest-ever Bundesliga goal
-
Verstappen on pole as he hunts first Singapore Grand Prix win
-
French prodigy Seixas becomes youngest Giro di Lombardia winner
-
Isaias drenches southern US as weakened post-tropical cyclone
-
Verstappen on pole position as he hunts first Singapore GP win
-
Australia strike early after Renshaw's 190 against South Africa
-
Arsenal learned lessons from Brighton collapse, says Arteta
-
India 'cockroach' movement says thousands detained during major protest in capital
-
Noosha Aubel: €143,056 in annual basic pay — while Potsdam’s residents are expected to serve as cash cows
-
Nobel peace laureate Pillay calls US sanctions on ICC 'unacceptable'
-
Cristiano Ronaldo provisionally suspended by Portugal after walkout
-
Roma goalkeeper Svilar sidelined for a month with broken finger
-
Brilliant Renshaw ton puts Australia in strong position
-
Proposed EU budget cut back in search for Christmas deal
-
Zelensky blasts diesel deal after Russian strikes kill 15
-
Arsenal hit back to beat Leeds and draw level with Man City
-
Cristiano Ronaldo provisionally suspended after Portugal walkout
-
Resurgent Zheng charges into China Open final with Andreeva
-
Alcaraz through in straight sets on Shanghai Masters opener
-
Spanish PM begins vote campaign overshadowed by housing protests
-
Palmer signs contract to stay at Chelsea until 2034
-
Putin told Trump about Iran's position on peace deal: Kremlin
-
India detains 'cockroach' movement leaders in bid to thwart election protest
-
Verstappen wins chaotic Singapore sprint after Russell crashes
-
Proposed next EU budget cut back in search for deal
-
Kiss tells Wallabies to 'return fire' after first loss as coach
-
All Blacks learn from 'failed' Springboks series to punish Wallabies
-
Russian strikes kill 11 including 3 children: Ukrainian authorities
-
Marquez grabs MotoGP championship lead after Indonesia sprint chaos
-
Russian teenager Andreeva breezes into China Open final
-
All Blacks extend Eden Park streak with big win over Wallabies
-
Major earthquake hits Panama, injures at least 27
-
Marquez grabs MotoGP championship lead with Indonesia sprint win
-
India detains 'cockroach' leaders ahead of election protest
-
Schauffele closes in on leaders after 'weird' round in Japan
-
'No divisions, no borders', French astronaut says of seeing Earth
-
Medvedev through at Shanghai Masters in first match since disqualification
-
India's 'cockroach' movement chief detained ahead of major protest
-
Trump sows doubt on plan to livestream US military execution
-
Year later, Gaza ceasefire promises mostly unfulfilled
-
Hunger and malnutrition stalk Gazans, a year on from ceasefire
-
Taiwan's leader says increasing defence spending to 'deter war'
US Justice Dept taking abortion pill fight to Supreme Court
The US Justice Department said Thursday that it will go to the Supreme Court to appeal restrictions imposed on a widely-used abortion pill in the latest round of an intensifying battle over reproductive rights.
The decision by President Joe Biden's administration came just hours after an appeals court rejected moves to ban mifepristone outright, but imposed a series of measures restricting access to the pill.
Mifepristone, which was approved by the Food and Drug Administration (FDA) in 2000 and accounts for more than half the abortions in the United States, has become the centerpiece of the country's latest clash over women's reproductive freedom.
Attorney General Merrick Garland said the Justice Department will be "seeking emergency relief from the Supreme Court to defend the FDA's scientific judgment and protect Americans' access to safe and effective reproductive care."
Speaking to reporters during Biden's visit to Dublin, Ireland, White House Press Secretary Karine Jean-Pierre said "we believe that the law is on our side, and we will prevail."
Late Wednesday, the US Fifth Circuit Court of Appeals said mifepristone, also known as RU 486, should remain available pending a full hearing of the case, but limited access to the first seven weeks of pregnancy, down from 10.
The appeals court also said in-person visits would be necessary to obtain the pill -- a requirement lifted in recent years -- and blocked the medication from being sent by mail.
The 2-1 ruling by the conservative-majority appeals court in New Orleans, Louisiana, came after a US District Court judge in Texas overturned the FDA's two-decades old approval of the drug last Friday.
- 'Furious' -
The appeals court said anti-abortion opponents had waited too long to challenge the drug's approval by the FDA but the judges' decision to impose restrictions on its use was denounced by groups seeking to maintain access to abortion.
"We are furious that yet another court would choose to jeopardize the health and futures of the millions of people who rely on mifepristone for abortion care," said Planned Parenthood president Alexis McGill Johnson.
Jennifer Dalven, director of the ACLU Reproductive Freedom Project, said "unless the Supreme Court steps in, this decision will prevent many people from getting abortion care and force them to remain pregnant against their will."
The anti-abortion group Susan B. Anthony described the appeals court ruling by two judges appointed by former Republican president Donald Trump as a "win."
"The court recognized that the abortion pill is dangerous and rolled back Biden's reckless mail-order abortion scheme," said Susan B. Anthony state policy director Katie Daniel. "We look forward to the Supreme Court hearing this case."
The latest standoff over abortion rights comes nearly a year after the Supreme Court, where conservatives wield a 6-3 majority, overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.
Mifepristone is one component of a two-drug regimen that can be used in the United States through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.
- 'Unborn human' -
Last week's ruling by Judge Matthew Kacsmaryk, also a Trump appointee, seeking to impose a nationwide ban on mifepristone came in response to a suit by a coalition of anti-abortion groups.
The judge, in his decision, adopted language used by abortion opponents, saying the drug was used to "kill the unborn human."
Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.
The Biden administration and leading pharmaceutical and biotech companies also argued that Kacsmaryk's ruling risked undermining the entire drug approval authority of the FDA.
"If this decision stands, no medication -- from chemotherapy drugs, to asthma medicine, to blood pressure pills, to insulin -- would be safe from attacks," said Vice President Kamala Harris.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access to the procedure -- or ban it outright.
A.Gasser--BTB